Terazosin Capsule
Product Images NDC 70518-0074

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 70518-0074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Terazosin 2mg 70518 0074 00

Terazosin 2mg 70518 0074 00
This text provides information about a medication called Terazosin in 2 mg capsules, with a quantity of 30 capsules. It includes prescription details, NDC number, manufacturing information, storage instructions, and the mention of directions for use. The medication is repackaged by RemedyRepack Inc. in Indiana.*
FDA Label Image

Terazosin 2mg 70518 0074 01

Terazosin 2mg 70518 0074 01
This text provides information about Terazosin capsules, each containing 2 mg of the active ingredient. The quantity is 30 capsules per pack. It indicates that the prescription is required, and includes the NDC number, manufacturing details, and storage instructions. The medication should be kept out of the reach of children and must be stored at a temperature range of 20-26°C (63-77°F). For further details on usage, it directs the user to the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.